Huntsman Carole
Insider CIK 2001571 · MDGL Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 419 | $431.94 | $181.0K | 12,692 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2026-03-04 | 2026-03-06 | 4,986 | — | $0 | 4,986 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2026-03-04 | 2026-03-06 | 3,989 | — | $0 | 13,111 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-26 | 2026-01-26 | 340 | $492.42 | $167.4K | 9,692 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-26 | 2026-01-26 | 570 | $494.59 | $281.9K | 9,122 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 40 | $553.23 | $22.1K | 10,552 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 894 | $550.97 | $492.6K | 11,096 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 80 | $564.57 | $45.2K | 10,032 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 40 | $563.21 | $22.5K | 10,112 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 80 | $560.62 | $44.8K | 10,152 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 200 | $559.60 | $111.9K | 10,232 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 120 | $556.04 | $66.7K | 10,432 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 200 | $552.38 | $110.5K | 10,592 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 40 | $549.34 | $22.0K | 10,792 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 120 | $548.71 | $65.8K | 10,832 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-21 | 2025-11-21 | 144 | $547.27 | $78.8K | 10,952 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-03-05 | 2025-03-07 | 5,703 | — | $0 | 5,703 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-03-05 | 2025-03-07 | 3,386 | — | $0 | 11,990 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 71 | $313.08 | $22.2K | 10,367 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 100 | $327.49 | $32.7K | 9,267 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 563 | $335.00 | $188.6K | 8,604 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 200 | $324.59 | $64.9K | 9,467 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 200 | $323.65 | $64.7K | 9,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 300 | $320.21 | $96.1K | 9,867 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 200 | $314.74 | $62.9K | 10,167 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 100 | $329.64 | $33.0K | 9,167 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 100 | $326.34 | $32.6K | 9,367 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-01-24 | 2025-01-27 | 347 | $335.24 | $116.3K | 10,438 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-11-21 | 2024-11-22 | 688 | $316.92 | $218.0K | 10,785 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-01-23 | 2024-01-25 | 5,483 | — | $0 | 5,483 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-01-23 | 2024-01-25 | 3,639 | — | $0 | 3,639 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-01-23 | 2024-01-25 | 3,639 | — | $0 | 11,473 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2023-11-20 | 2023-11-22 | 10,077 | — | $0 | 10,077 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-11-20 | 2023-11-22 | 7,834 | — | $0 | 7,834 | SEC↗ |